Search for Clinical Trial Results

Sponsored By

Dermatofibrosarcoma - 15 Studies Found

Status Study
Completed Study Name: Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
Condition: Dermatofibrosarcoma
Date: 2005-07-20
Interventions: Drug: Imatinib (Glivec)
Completed Study Name: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
Condition: Dermatofibrosarcoma Protuberans
Date: 2005-10-20
Interventions: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days
Terminated Study Name: Phase II Pazopanib Study in Advanced Dermatofibrosarcomas
Condition: Dermatofibrosarcomas of DARIER FERRAND(DFSP)
Date: 2010-01-28
Interventions: Drug: Pazopanib Administration of pazopanib per os 800mg/ qd during 6 months until stable response accor
Completed Study Name: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
Condition:
  • Adult Fibrosarcoma
  • Dermatofibrosarcoma Protuberans
  • Date: 2004-06-10
    Interventions:
    • Drug: imatinib mesylate Given

Completed Study Name: Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
Condition: Soft Tissue Neoplasms
Date: 2005-09-12
Completed Study Name: Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
Condition: Sarcoma
Date: 2004-06-10
Interventions:
  • Drug: imatinib mesylate
  • Procedure: convent
Completed Study Name: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Condition:
  • Hypereosinophilic Syndrome
  • Systemic Mastocytosis
  • Chronic M
    Date: 2005-09-13
    Interventions: Drug: imatinib mesylate Other Name: STI571
Recruiting Study Name: Spanish Registry of Mohs Surgery
Condition:
  • Skin Neoplasms
  • Carcinoma, Basal Cell
  • Carcinoma, Squamous C
    Date: 2014-12-01
    Interventions: Procedure: Mohs surgery A surgical technique used primarily in the treatment of skin neoplasms, especial
Recruiting Study Name: To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Condition:
  • Neuroblastoma
  • Rhabdomyosarcoma
  • Ewing's Sarcoma
  • Date: 2013-09-27
    Interventions: Drug: nab-paclitaxel nab-paclitaxel 100-240 mg/m2 IV on Days 1, 8 and 15 of a 28-day cycle
Completed Study Name: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition:
  • Adult Fibrosarcoma
  • Adult Leiomyosarcoma
  • Adult Liposarcoma<
    Date: 2008-04-15
    Interventions: Drug: saracatinib Given orally Other Name: AZD0530
Next >>>